Zepto Overview

  • Founded
  • 2008
Founded
  • Status
  • Private
  • Latest Deal Type
  • Later Stage VC
  • Latest Deal Amount
  • $25M
Latest Deal Amount
  • Investors
  • 6

Zepto General Information

Description

Developer of a surgical device designed to advance the safety and precision of cataract surgery outcomes. The company's device is a disposable instrument that provides quick, consistent and high quality automated capsulotomies that can be personalized for the patient's individual visual axis in routine, challenging and premium cases of cataract surgery, enabling doctors to automate the anterior capsulotomy by reducing risk, increase edge strength and improve precision in cataract procedures.

Contact Information

Formerly Known As
Mynosys Cellular Devices
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Surgical Devices
Primary Office
  • 1939 Palomar Oaks Way
  • Suite A
  • Carlsbad, CA 92011
  • United States
+1 (833) 000-0000

Zepto Timeline

2018201920202021
Financing Round
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Zepto Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Later Stage VC 09-Oct-2019 $25M 000.00 Completed Generating Revenue
7. Grant 01-Aug-2017 00.000 00.000 Completed Generating Revenue
6. Accelerator/Incubator 07-Feb-2017 00.000 Completed Generating Revenue
5. Later Stage VC 18-May-2016 00.000 00.000 Completed Generating Revenue
4. Later Stage VC (Series B) 01-Mar-2016 000 Completed Generating Revenue
3. Later Stage VC (Series A) 17-Sep-2015 00000 000 Completed Generating Revenue
2. Seed Round 08-Sep-2014 $1.32M $1.32M 000.00 Completed Generating Revenue
1. Grant 01-Jan-2013 $2.04M Completed Generating Revenue
To view Zepto’s complete valuation and funding history, request access »

Zepto Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.00
To view Zepto’s complete cap table history, request access »

Zepto Executive Team (5)

Name Title Board Seat Contact Info
Louis Bunn Chief Financial Officer
Christopher Keller Co-Founder & Chief Technology Officer
Robert Thornhill President, Chief Executive Officer & Board Member
David Sretavan Ph.D Co-Founder & Board Member
You’re viewing 4 of 5 executive team members. Get the full list »

Zepto Board Members (7)

Name Representing Role Since
David Sretavan Ph.D Self Co-Founder & Board Member 000 0000
Gilbert Kliman MD Self Board Member 000 0000
James Mazzo Self Board Member 000 0000
Jeffry Weinhuff Visionary Venture Fund Board Observer 000 0000
Nick Pliam Ph.D Decheng Capital Board Member 000 0000
You’re viewing 5 of 7 board members. Get the full list »

Zepto Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Decheng Capital Venture Capital Minority 000 0000 000000 0
National Eye Institute Government 000 0000 000000 0
National Institutes of Health Government 000 0000 000000 0
California Institute for Quantitative Biosciences Accelerator/Incubator Minority 000 0000 000000 0
Visionary Venture Fund Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »